Related Experiment Video
Updated: May 24, 2026

Creating Radio-cephalic Arteriovenous Fistula in the Forearm with a Modified No-Touch Technique
Published on: April 1, 2022
Percutaneous approach in the maintenance and salvage of dysfunctional autologous vascular access for dialysis
Paola De Rango1, Basso Parente, Enrico Cieri
1Unit of Vascular and Endovascular Surgery, Hospital S. M. Misericordia and University of Perugia, Perugia, Italy. pderango@unipg.it
Insights
Endovascular angioplasty offers a safe and effective method for salvaging failing vascular access, serving as a repeatable, cost-effective bridge solution. While mid-term durability is limited, it can prolong access survival and avoid repeat surgeries.
Area of Science:
- Vascular Surgery
- Interventional Radiology
- Nephrology
Background:
- Endovascular procedures are increasingly utilized for failing vascular access, but outcomes remain debated.
- Assessing mid-term patency and complication rates is crucial for treatment planning.
Purpose of the Study:
- To evaluate the mid-term patency and complication rates of endovascular angioplasty for treating stenosis in failing vascular accesses.
- To compare endovascular outcomes with open surgical procedures.
Main Methods:
- A prospective database of vascular accesses from 2006-2010 was analyzed.
- 531 consecutive procedures were reviewed, focusing on 64 endovascular angioplasties for stenosis.
- Patency rates were calculated using the Kaplan-Meier method.
Main Results:
- Endovascular angioplasty achieved a 95.3% immediate technical success rate with a 6.3% complication rate.
- Primary patency rates for angioplasty were 55% at 6 months, 49% at 12 months, and 21% at 24 months.
- Surgical reintervention showed higher initial patency (80% at 6 months) but similar 24-month rates (49%); angioplasty incurred additional costs.
Conclusions:
- Endovascular angioplasty is a safe and effective option for most dysfunctional vascular accesses.
- Despite limited mid-term durability, angioplasty serves as a repeatable, cost-effective bridge to prolong access survival.
- High mid-term failure rates can also occur after surgical reintervention.
Purpose:
Endovascular procedures have been increasingly used for salvage of failing vascular access with conflicting results. The aim of this study was to assess the mid-term patency and complication rates of angioplasty procedures performed in a single center for treatment of stenosis compromising vascular accesses.
Methods:
A prospective database of vascular accesses performed in 2006-2010 was investigated. The endovascular approach was applied following a standardized protocol by a dedicated team. A total of 531 consecutive procedures were reviewed (326 men; mean age 70.94 years). Patency rates were estimated using the Kaplan-Meier method.
Results:
There were 199 procedures for failing access: 135 were surgical and 64 angioplasties performed for anastomosis (n=27), venous (n=45) or arterial (n=7) stenosis. Immediate technical success of endovascular procedures was 95.3%(61/64); complication rate was 6.3% (4/64). Primary patency rates were 55% at six months, 49% at 12 months, and 21% at 24 months. In the concurrent group of 135 open procedures, primary patency rates were 80% at six months and 67% at 12 months (P=.002); nevertheless, at 24 months, patency was as low as 49%. Cost estimates for angioplasty revealed additional fees ranging from 411.34 to 446.34 Euro with respect to open surgical procedures.
Conclusions:
Most dysfunctional vascular accesses can be successfully and safely treated by the endovascular route. In spite of poor mid-term durability, the angioplasty balloon might be considered as a bridge, effective, and repeatable solution with reasonable costs to prolong access survival avoiding additional surgery. The failure rate in the mid-term for dysfunctional vascular access may also be high after surgical reintervention.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Continuous Renal Replacement Therapy
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

